← Back to Intel
Insider ActivitySNDX
Metzger Michael A, Chief Executive Officer at Syndax Pharmaceuticals Inc, sold $130K of SNDX
Updated Jun 6, 2026
Metzger Michael A
Chief Executive Officer
Syndax Pharmaceuticals Inc ·
$SNDX
Transaction Details
| Insider | Metzger Michael A |
|---|---|
| Title | Chief Executive Officer |
| Company | Syndax Pharmaceuticals Inc |
| Ticker | SNDX |
| Transaction Type | Sale |
| Transaction Date | 2026-06-01 |
| Shares Traded | 6,847 |
| Price Per Share | $18.99 |
| Total Value | $130K |
| Filed Date | 2026-06-02 |
| Accession Number | 0001193125-26-253601 |
Ownership Context
| Shares Owned After Transaction | 484,843 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001193125-26-253601
Other Insider Trades — SNDX
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Goldan Keith A. | Chief Financial Officer | sold | $22K | 2026-06-01 |
Other Trades by Metzger Michael A
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | traded | — | 2026-03-24 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SNDX — Syndax Pharmaceuticals Inc →
Whisper Score — SNDX
53.9
Active Discussion
Current Whisper Score
Track SNDX insider activity in real time on The Wire →
Get alerts when Metzger Michael A files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 06, 2026 at 07:01 UTC